Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

May 24, 2016

Primary Completion Date

April 13, 2020

Study Completion Date

September 28, 2020

Conditions
Macular EdemaCentral Retinal Vein Occlusion
Interventions
DRUG

Conbercept Ophthalmic Injection

"Subject receive 0.5 mg Conbercept injection into their study eyes every month (Day 0 - Month 5).~If subjects meets the criteria for repeated administration, the subject receives 0.5 mg Conbercept injection into the study eye (Month 6 \~ 11)."

DRUG

sham injection

"Subjects receive sham injection into their study eyes every month (Day 0 - Month 5).~Subjects receive a single intravitreal injection of 0.5 mg Conbercept ophthalmic injection in month 6, followed monthly review, if he/she meets the criteria for repeated administration, the subject receives 0.5 mg Conbercept injection into the study eye (Month 6 \~ 11)."

Trial Locations (27)

Unknown

Beijing Friendship Hospital,Capital Medical University, Beijing

Beijing Tongren Hospital, Capital Medical University, Beijing

Peking Union Medical College Hospital, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

Peking University Third Hospital, Beijing

The General Hospital of the People's Liberation Army, Beijing

The Second Hospital of Jilin University, Changchun

The Second Xiangya Hospital of Central South University, Changsha

West China Hospital Sichuan University, Chengdu

Army Medical Center, Chongqing

The Second Hospital of Dalian Medical University, Dalian

Zhongshan Ophthalmic Center, Guangzhou

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

The Jiangxi Provincial People's Hospital, Nanchang

Nanjing First Hospital, Nanjing

The First Affiliated Hospital of Guangxi Medical University, Nanning

Eye & Ent Hospital of Fudan University, Shanghai

Shanghai General Hospital, Shanghai

Zhongshan Hospital, Shanghai

The First Hospital of China Medical University, Shenyang

Tianjin Eye Hospital, Tianjin

Tianjin Medical University Eye Hospital School of Optometry & Eye Institute, Tianjin

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Eye Hospital,WMU Zhejiang Eye Hospital, Wenzhou

Wuhan General Hospital of Guangzhou Military Command, Wuhan

The First Affiliated Hospital of Xi'An Jiaotong University, Xi'an

All Listed Sponsors
lead

Chengdu Kanghong Biotech Co., Ltd.

INDUSTRY

NCT03223714 - Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter